Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Descriptive Study of Patients Receiving Excision and Radiotherapy for Keloids

Journal Article · · International Journal of Radiation Oncology, Biology and Physics
 [1]; ;  [2]
  1. Department of Medical Oncology, Jewish General Hospital, McGill University, Montreal, QC (Canada)
  2. Department of Radiation Oncology, Jewish General Hospital, McGill University, Montreal, QC (Canada)
Purpose: To review and describe our institution's outcomes in patients treated with external beam radiotherapy after keloid excision. Methods and Materials: This was a retrospective study. Patients who received radiotherapy between July 1994 and January 2004 after keloid excision were identified. A questionnaire was mailed regarding sociodemographic factors, early and late radiation toxicities, the need for additional therapy, and satisfaction level. All patients had received a total of 15 Gy in three daily 5-Gy fractions. Treatment started within 24 h after surgery and was delivered on a Siemens orthovoltage machine. The data were analyzed using the STATA statistical package. Results: A total of 234 patients were approached. The response rate was 41%, and 75% were female. The mean age was 36.5 years (range, 16-69 years). The patients were mainly of European (53.1%) or African (19.8%) descent. For early toxicity outcomes, 54.2% reported skin redness and 24% reported skin peeling. For late toxicity outcomes, 27% reported telangiectasia and 62% reported permanent skin color changes. No association was found with gender, skin color, or age for the late toxicity outcomes. Of the patients responding, 14.6% required adjuvant treatment. On a visual scale of 1-10 for the satisfaction level, 60% reported a satisfaction level of {>=}8. Telangiectasia was the most significant predictor of a low satisfaction level ({<=}3, p < 0.005). Conclusion: The results of our study have shown that orthovoltage-based radiotherapy after surgical excision for keloids is a good method for the prevention of relapse. It is well tolerated, causes little toxicity, and leads to a high patient satisfaction level.
OSTI ID:
21124403
Journal Information:
International Journal of Radiation Oncology, Biology and Physics, Journal Name: International Journal of Radiation Oncology, Biology and Physics Journal Issue: 5 Vol. 71; ISSN IOBPD3; ISSN 0360-3016
Country of Publication:
United States
Language:
English

Similar Records

Postoperative Strontium-90 Brachytherapy in the Prevention of Keloids: Results and Prognostic Factors
Journal Article · Wed Apr 01 00:00:00 EDT 2009 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:21276751

Perioperative Interstitial High-Dose-Rate Brachytherapy for the Treatment of Recurrent Keloids: Feasibility and Early Results
Journal Article · Mon Feb 29 23:00:00 EST 2016 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:22645102

Association Between Maximal Skin Dose and Breast Brachytherapy Outcome: A Proposal for More Rigorous Dosimetric Constraints
Journal Article · Mon Oct 31 20:00:00 EDT 2011 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:21590460